pneumoconiosis
Asbestosis is a chronic, progressive, diffuse, irreversible pulmonary interstitial fibrosis, pleural plaque formation and pleural hypertrophy caused by long-term inhalation of asbestos dust. It seriously damages the patient's lung function and can significantly increase the incidence of malignant tumors of the lung and pleura.
Related Drugs
Tulobuterol Hydrochloride Tablets
Indication: Bronchial asthma, acute bronchitis, chronic asthmatic bronchitis, emphysema, silicosis, pneumoconiosis and other respiratory obstructive diseases.
Manufacturer:
Shaanxi Xuelong Haimu Pude Pharmaceutical Co., Ltd.
Tulobuterol Hydrochloride Tablets
Indication: Bronchial asthma, acute bronchitis, chronic asthmatic bronchitis, emphysema, silicosis, pneumoconiosis and other respiratory obstructive diseases.
Manufacturer:
Xi`an Han Feng Pharmaceutical Co., Ltd.
Tulobuterol Hydrochloride Tablets
Indication: Bronchial asthma, acute bronchitis, chronic asthmatic bronchitis, emphysema, silicosis, pneumoconiosis and other respiratory obstructive diseases.
Manufacturer:
Xi`an Han Feng Pharmaceutical Co., Ltd.
Tulobuterol Hydrochloride Tablets
Indication: Bronchial asthma, acute bronchitis, chronic asthmatic bronchitis, emphysema, silicosis, pneumoconiosis and other respiratory obstructive diseases.
Manufacturer:
China Resources 39 (Beijing) Pharmaceutical Co., Ltd.
Fudosteine Tablets
Indication: Used for expectorant treatment of respiratory diseases such as bronchial asthma, chronic asthmatic bronchitis, bronchiectasis, pulmonary tuberculosis, pneumoconiosis, chronic obstructive pulmonary emphysema, atypical mycobacterial disease, pneumonia, diffuse bronchitis, etc.
Manufacturer:
Sichuan Kelun Pharmaceutical Co., Ltd.
Fudosteine Tablets
Indication: Used for expectorant treatment of respiratory diseases such as bronchial asthma, chronic asthmatic bronchitis, bronchiectasis, pulmonary tuberculosis, pneumoconiosis, chronic obstructive pulmonary emphysema, atypical mycobacterial disease, pneumonia, diffuse bronchitis, etc.
Manufacturer:
Chiatai Qingchunbao Pharmaceutical Co., Ltd.
Fudosteine
Indication: Used for expectorant treatment of respiratory diseases such as bronchial asthma, chronic asthmatic bronchitis, bronchiectasis, tuberculosis, pneumoconiosis, emphysema, chronic obstructive pulmonary emphysema, atypical mycobacteria, pneumonia, diffuse bronchitis, etc.
Manufacturer:
Lianyungang Runzhong Pharmaceutical Co., Ltd.
Fudosteine Capsules
Indication: Used for expectorant treatment of respiratory diseases such as bronchial asthma, chronic asthmatic bronchitis, bronchiectasis, tuberculosis, pneumoconiosis, emphysema, chronic obstructive pulmonary emphysema, atypical mycobacteria, pneumonia, diffuse bronchitis, etc.
Manufacturer:
Sichuan Kelun Pharmaceutical Co., Ltd.